EUVIMEDEUVIMED entdecken
Crossref

Inhibition of cytochrome P450 2B6 activity by kava extracts

Pan-Fen Wang, Bharathi Avula, Kumar Katragunta, Amar G Chittiboyina, Evan D Kharasch

Drug Metabolism and Disposition · 2026-10 · 54 (10) · 100395

DOI: 10.1016/j.dmd.2026.100395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-10. Verfasst von Pan-Fen Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina. Hauptthemen laut MEDLINE: Kava, Plant Extracts, Cytochrome P-450 CYP2B6, Cytochrome P-450 CYP2B6 Inhibitors. Die Arbeit nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kava is a beverage prepared from the rhizomes and roots of the tropical evergreen plant Piper methysticum. Kava contains 6 major kavalactones. Legacy studies found that kavalactones did not inhibit human cytochrome P450s in vitro at relevant concentrations, and kava did not inhibit the major P450s in humans in vivo and was devoid of clinically significant drug interactions. Nevertheless, CYP2B6 was never evaluated. Recent investigation identified that (+)-dihydromethysticin, 1 of the 6 natural kavalactones, was an inhibitor of CYP2B6 in vitro. This investigation evaluated the effects of kava extract and (+)-dihydromethysticin on expressed CYP2B6 activity-both wild-type CYP2B6.1 and active allelic variant CYP2B6.4. Effects on human liver microsomal CYP2B6 were also evaluated. Two independent kava extracts inhibited expressed and human liver microsomal CYP2B6 activity, in a concentration-dependent manner, assessed using the CYP2B6 probe substrates 7-ethoxy-4-trifluoromethyIcoumarin O-deethylation and S-ketamine N-demethylation. Ki values for CYP2B6 inhibition by (+)-dihydromethysticin alone and in kava extracts were 0.01-0.05 μM. Kava and (+)-dihydromethysticin interaction with expressed CYP2B6.1 and CYP2B6.4 generated a difference spectrum consistent with formation of a metabolite-inhibitor complex. (+)-Dihydromethysticin underwent NADPH-dependent metabolism by expressed CYP2B6 and human liver microsomes. These results show that kava extracts inhibit CYP2B6, an effect attributed to (+)-dihydromethysticin, which appears to act as a mechanism-based inhibitor. Because kava consumption achieves plasma (+)-dihydromethysticin concentrations exceeding the inhibitory Ki, there is a potential risk of in vivo CYP2B6-mediated herb-drug interactions. Such potential merits clinical drug-herb interaction studies using standard CYP2B6 substrate probes. SIGNIFICANCE STATEMENT: Kava extracts are widely used as botanical supplements for managing various health conditions. Kava extracts showed concentration-dependent inhibition of CYP2B6 in both expressed systems and human liver microsomes. Inhibition was attributed to (+)-dihydromethysticin. Spectral and metabolism studies suggested that CYP2B6 catalyzed the formation of a metabolite-inhibitor complex with (+)-dihydromethysticin alone and present in the extracts. Typical kava consumption yields plasma (+)-dihydromethysticin concentrations that exceed the inhibitory Ki; thus, showing a clear potential for clinically relevant in vivo CYP2B6-mediated herb-drug interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KavaPlant ExtractsCytochrome P-450 CYP2B6Cytochrome P-450 CYP2B6 InhibitorsPyronesHumansMicrosomes, LiverHerb-Drug InteractionsPyrans

Stichwörter der Autor:innen

CYP2B6DihydromethysticinDrug interactionsKavaKavalactone

Substanzen

Plant ExtractsCytochrome P-450 CYP2B6Cytochrome P-450 CYP2B6 InhibitorsCYP2B6 protein, humanPyrones7,8-dihydromethysticinPyrans

Autor:innen und Institutionen

  • Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina.
  • National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, Mississippi.
  • National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, Mississippi; Department of BioMolecular Sciences, School of Pharma…
  • Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina; Bermaride LLC, Durham, North Carolina. Electronic address: evan.kharasch@duke.edu.

Zitieren

APA

Wang, P. F., Avula, B., Katragunta, K., Chittiboyina, A. G., & Kharasch, E. D. (2026). Inhibition of cytochrome P450 2B6 activity by kava extracts. Drug Metabolism and Disposition, 54(10), 100395. https://doi.org/10.1016/j.dmd.2026.100395

Vancouver

Wang PF, Avula B, Katragunta K, Chittiboyina AG, Kharasch ED. Inhibition of cytochrome P450 2B6 activity by kava extracts. Drug Metabolism and Disposition. 2026;54(10):100395. doi:10.1016/j.dmd.2026.100395

BibTeX
@article{Wang2026,
  author = {Wang, Pan-Fen and Avula, Bharathi and Katragunta, Kumar and Chittiboyina, Amar G and Kharasch, Evan D},
  title = {Inhibition of cytochrome P450 2B6 activity by kava extracts},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  volume = {54},
  number = {10},
  pages = {100395},
  doi = {10.1016/j.dmd.2026.100395}
}
Kostenlos starten →